Question 1

What are the most cited papers from Therapyx (United States)?

Accepted Answer

The most cited paper from Therapyx (United States) is "Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2Rγnull Mice" (Michelle R. Simpson-Abelson, Gregory F. Sonnenberg, Hiroshi Takita et al., 2008), with 94 citations. Next come "Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae" (38) and "Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae" (37).

Question 2

Which research topics does Therapyx (United States) publish most on?

Accepted Answer

By volume in 2022-now: T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction and Bacterial Infections and Vaccines.

Question 3

Which fields of science does Therapyx (United States) work in?

Accepted Answer

In all years, 59% of research at Therapyx (United States) is in Life Sciences, 41% in Health Sciences. Its largest fields are Immunology and Microbiology (52%), Medicine (41%), Biochemistry, Genetics and Molecular Biology (7%). It does 1.4× the world's share of Life Sciences.

Question 4

Is Therapyx (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 151% higher than in 2018-2021.